Tidal Investments’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
114,506
+12,749
+13% +$168K ﹤0.01% 1461
2026
Q1
$1.4M Buy
101,757
+11,047
+12% +$166K ﹤0.01% 1290
2025
Q4
$1.64M Sell
90,710
-3,540
-4% -$63.6K ﹤0.01% 1034
2025
Q3
$1.75M Sell
94,250
-1,907
-2% -$30K ﹤0.01% 965
2025
Q2
$1.54M Buy
96,157
+36,402
+61% +$649K 0.01% 837
2025
Q1
$1.16M Sell
59,755
-23,737
-28% -$500K 0.01% 917
2024
Q4
$1.84M Sell
83,492
-20,986
-20% -$404K 0.01% 735
2024
Q3
$1.76M Buy
104,478
+38,887
+59% +$577K 0.02% 722
2024
Q2
$784K Buy
65,591
+6,603
+11% +$73.8K 0.01% 1030
2024
Q1
$654K Buy
+58,988
New +$602K 0.01% 1081

Other funds holding CLBT

Tidal Investments's CLBT Position: Q2 2026 in Review

Tidal Investments increased its Cellebrite (CLBT) stake by 13% in Q2 2026, buying an estimated $168K and bringing the position to 114,506 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1461.

Tidal Investments first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.84M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Tidal Investments held 114,506 shares of Cellebrite worth $1.67M as of Q2 2026.
  • Tidal Investments bought 12,749 Cellebrite shares in Q2 2026, an estimated $168K.
  • Cellebrite made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1461 holding.
  • Tidal Investments first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
  • Tidal Investments's Cellebrite position peaked at $1.84M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.